PAR 3.88% 49.5¢ paradigm biopharmaceuticals limited..

Lets tonight, do a very high level comparison with some of the...

  1. 19 Posts.
    lightbulb Created with Sketch. 2
    Lets tonight, do a very high level comparison with some of the treatments that PPS is up against. Depending on the aliment there are various methods of treatment including the ones below and surgery too. Surgery itself is usually deemed to be the last line of treatment and has its own set of side effects and disadvantages not covered in this analysis.

    I'm not a doc, do you own research, standard disclaimers apply, but even with this simple summary, in my opinion, PAR is on to something quite amazing. Just give it a couple of years and lets have a chat over a beer (tea?) and laugh at when it was just $1.55 per share!?

    TREATMENTSIDE EFFECTS
    1Non Steroidal anti inflammatory drugs (NSAIDS)Can cause stomach ulcers, in some cases bleeding
    2
    Can worsen symptoms, can cause kidney damage and increased
    3
    risk of heart attack/strokes
    4

    5CorticosteroidsCan itself result in fragile bones, can lead to higher blood pressure, weight gain
    6
    Can cause glaucoma (increased pressure in eyes)
    7
    Can be addictive and lead to psychological problems
    8

    9OpoidsHighly addictive, just masks pain, doesn't actually repair anything!
    10

    11PPSNo known side effects that are serious.
    12
    In some cases MAY cause headaches, nausea

    References
    https://www.medicalnewstoday.com/articles/248423.php
    1https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171914/
    & PAR web site.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
49.5¢
Change
-0.020(3.88%)
Mkt cap ! $82.30M
Open High Low Value Volume
51.0¢ 52.5¢ 49.0¢ $492.8K 981.6K

Buyers (Bids)

No. Vol. Price($)
4 18016 49.0¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 43020 2
View Market Depth
Last trade - 16.10pm 03/12/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.